Form 4: Biodesix Executive Converts Preferred Stock to Common Stock

Gary Anthony Pestano, Chief Development Officer of Biodesix Inc., converted Series A Non-Voting Convertible Preferred Stock into Common Stock on May 23, 2024, following stockholder approval.

Summary

• On May 23, 2024, Gary Anthony Pestano, the Chief Development Officer of Biodesix Inc., converted shares of Series A Non-Voting Convertible Preferred Stock into Common Stock.
• This conversion occurred after the company's stockholders approved the conversion at the annual meeting held on May 21, 2024.
• Each share of Preferred Stock was automatically converted into 40 shares of Common Stock.
• Pestano converted 22 shares of Preferred Stock into 880 shares of Common Stock.
• Following the transaction, Pestano directly owns 125,128 shares of Biodesix Common Stock.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to an insider stock conversion, which is neither overwhelmingly positive nor negative. The conversion simplifies the capital structure, which is a slightly positive signal.

Positives

• The conversion of preferred stock to common stock simplifies the company's capital structure.

Industry Context

Insider transactions are routinely monitored to gauge executive sentiment and potential future performance of the company. Conversions of preferred stock to common stock can be seen as a simplification of the capital structure.

Stakeholder Impact

• The conversion of preferred stock to common stock could have a minor dilutive effect on existing common shareholders.

Key Dates